In the 88 patients who received 30 mgkgweek of EXONDYS 51 for up to 208 weeks in clinical studies the following events were reported in 10 of patients and occurred more frequently than on the same dose in Study 1 vomiting contusion excoriation arthralgia rash catheter site pain and upper respiratory tract infection